The risk stratification criteria used in the CHAARTED and LATITUDE trials can accurately assess prognosis in patients with castration-resistant prostate cancer (CRPC), but are insufficient to differentiate between the therapeutic outcomes of androgen receptor pathway inhibitors (ARPI) and docetaxel, a new study has found.
Levels of prostate specific antigen (PSA) mRNA in circulating tumour cells can be used alongside serum PSA protein levels to refine the assessment of disease progression in patient with metastatic castration-resistant prostate cancer (mCRPC), a new study has found.
In patients with clinically localized Gleason 9–10 prostate cancer, dose-escalated radiotherapy confers better biochemical disease-free survival and prostate cancer-specific mortality than conventional doses, a recent study has found.
Interspinous diameter seems to be an important factor affecting the difficulty of laparoscopic surgery in patients with mid-low rectal cancer, suggesting that magnetic resonance imaging (MRI) pelvimetry is helpful in gauging the technical difficulty of rectal surgery, a recent study has found.
Magnetic resonance imaging (MRI)-targeted biopsy misses of clinically significant cancers seldom occur, but such rare cases are mostly caused by errors in lesion targeting, which underscores the importance of accurate coregistration and targeting when using software-based fusion platforms, according to a study. Moreover, some patients harbor MRI-invisible lesions, which cannot be targeted by MRI platforms.
A prolonged gap between biopsy and robot-assisted radical prostatectomy (RARP) does not significantly influence the likelihood of biochemical recurrence (BCR) in prostate cancer patients, even in those who are considered high-risk, a recent Japan study has found.